JPS60250014A - Concentrating resin - Google Patents
Concentrating resinInfo
- Publication number
- JPS60250014A JPS60250014A JP10646484A JP10646484A JPS60250014A JP S60250014 A JPS60250014 A JP S60250014A JP 10646484 A JP10646484 A JP 10646484A JP 10646484 A JP10646484 A JP 10646484A JP S60250014 A JPS60250014 A JP S60250014A
- Authority
- JP
- Japan
- Prior art keywords
- water
- aqueous solution
- acrylamide
- resin
- meth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
定の(メタ)アクリルアミド誘導体の重合体を水に不溶
化してなる濃縮用樹脂に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a concentration resin made by making a polymer of a certain (meth)acrylamide derivative insoluble in water.
従来技術とその問題点:
従来、水溶液の濃縮に使用される具体的な方法としては
、(1)逆浸透膜、限外E過膜等の膜により分離する方
法、(2)多段フラノシー蒸発法、凍結法等の水の相変
化により分離する方法等があり、実用に供されている。Conventional techniques and their problems: Conventionally, specific methods used to concentrate aqueous solutions include (1) separation using a membrane such as a reverse osmosis membrane or an ultra-E filtration membrane, and (2) multi-stage Furanosee evaporation method. There are methods of separation by phase change of water, such as freezing method, etc., which are in practical use.
しかし、いづれの方法においても、たとえば膜分離にお
いては膜汚染等の問題が、相変化による分離においては
エイ・ルギー効率が問題となり、必ずしも満足し得るも
のではなく、種々の改良が試みられている。特に蒸発法
などでは濃縮の困難な食品、アミノ酸、たんばく質、多
糖類、酵素、エマルション等の熱により変質し易い物質
等の濃縮において大きな問題になっている。However, with either method, problems such as membrane contamination occur in membrane separation, and energy efficiency is a problem in phase change separation, and these methods are not always satisfactory, and various improvements have been attempted. . In particular, this is a big problem when concentrating substances that are difficult to concentrate using evaporation methods, such as foods, amino acids, proteins, polysaccharides, enzymes, emulsions, and other substances that are easily altered by heat.
問題点を解決するための手段:
上記した点に鑑み、本発明者らは保水ゲルの吸水及び放
水について検討していた妻ころ、特定の(メタ)アクリ
ルアミド誘導体の重合体を水に不溶化したものは温度に
より変化する吸水能を有し、大過剰の水の存在下におい
ても加温により収縮して吸収した水を放出する性質を有
し、その性質を利用することにより再生使用可能であり
、かつ分子量分画可能な濃縮剤になることを見い出し、
本発明に到った。Means for solving the problem: In view of the above points, the present inventors were studying the water absorption and water release of water-retaining gels, and developed a polymer made of a specific (meth)acrylamide derivative that was made insoluble in water. It has a water absorption capacity that changes depending on the temperature, and even in the presence of a large excess of water, it has the property of contracting and releasing the absorbed water when heated, and by utilizing this property, it can be recycled and reused. We discovered that it is a condensing agent that can be fractionated by molecular weight.
We have arrived at the present invention.
即ち、本発明は、一般式(I)または一般式(Illで
表わされる
一般式
(上式でR1は水素原子またはメチル基、川は水素原子
、メチル基またはエチル基、R3はメチル基、エチル基
またはプロピル基を表わす。)一般式
(上式でR,は水素原子またはメチル基、Aは+CH2
+rlでnは4−6または+CR2−);、 0÷CH
2−%を表わす。)N−アルキルまたはN−アルキレン
置換(メタ)アクリルアミドの単独または共重合体、も
・しくけ他の共重合しうる単量体との共重合体を水に不
溶化してなる濃縮用1匍脂である。That is, the present invention provides a general formula (I) or a general formula (Ill) (in the above formula, R1 is a hydrogen atom or a methyl group, R3 is a hydrogen atom, a methyl group or an ethyl group, and R3 is a methyl group, an ethyl group). or propyl group.) General formula (In the above formula, R is a hydrogen atom or a methyl group, A is +CH2
+rl and n is 4-6 or +CR2-);, 0÷CH
Represents 2-%. 1 liter fat for concentration made by insoluble in water a single or copolymer of N-alkyl or N-alkylene substituted (meth)acrylamide, or a copolymer with other copolymerizable monomers It is.
本発明において用いられるN−アルキルまたはN−アル
キレン置換(メタ)アクリルアミド単量体としては、た
とえばN −n−プロピルアクリルアミド、N −n−
プロピルメタクリルアミド、N−イソプロピルアクリル
、アミド、N−インプロピルメタクリルアミド、N−エ
チルアクリルアミド、N、 N−ジエチルアクリルアミ
ド、N−エチルメタクリルアミド、N、 N−ジメチル
アクリルアミド、N、 N−ジメチルメタクリルアミド
、N−アクリロイルピロリジン、N−メタクリロイルピ
ロ、リジン、N−アクリロイルピペリジン、N−メタク
リロイルピペリジン、N−アクリロイルモルホリン等を
あげることができる。Examples of the N-alkyl- or N-alkylene-substituted (meth)acrylamide monomer used in the present invention include N-n-propylacrylamide, N-n-
Propylmethacrylamide, N-isopropylacrylamide, N-inpropylmethacrylamide, N-ethylacrylamide, N,N-diethylacrylamide, N-ethylmethacrylamide, N,N-dimethylacrylamide, N,N-dimethylmethacrylamide , N-acryloylpyrrolidine, N-methacryloylpyro, lysine, N-acryloylpiperidine, N-methacryloylpiperidine, N-acryloylmorpholine, and the like.
また、上記した単量体と共重合可能な単量体としては、
親水性単量体、イオン性単量体、親油性単量体等があげ
られ、それらの一種以上の単量体が適用できる。具体的
には親水性単量体として、たとえばアクリルアミド、メ
タクリルアミド、N−メチルアクリルアミド、ジアセト
ンアクリルアミド、ヒドロキシエチルメタクリレート、
ヒドロキシエチルアクリレート、ヒドロキシプロピルメ
タクリレート、ヒドロキシプロピルアクリレート、各種
のメトキシポリエチレングリコールメタクリレート、各
種のメトキシポリエチレングリコールアクリレート、N
−ビニル−2−ピロリドン等をあげることができるし、
また、酢酸ビニル、グリシジルメタクリレート等を共重
合により導入して、それを加水分解して親水性を賦与す
ることもできる。イオン性単量体としては、たとえはア
クリル啼、メタクリル酸、ビニルスルホン酸、アリルス
ルホン酸、メタリルスルホン酸、スチレンスルホンン浚
、2−アクリルアミl’−2−フェニルフ“ロパンスル
ホン酸、2−アクリルアミド−2−メチル−プロパンス
ルホン1酸等の、・浚及びそれらの塩、N。In addition, monomers that can be copolymerized with the above monomers include:
Examples include hydrophilic monomers, ionic monomers, lipophilic monomers, etc., and one or more of these monomers can be applied. Specifically, examples of hydrophilic monomers include acrylamide, methacrylamide, N-methylacrylamide, diacetone acrylamide, hydroxyethyl methacrylate,
Hydroxyethyl acrylate, hydroxypropyl methacrylate, hydroxypropyl acrylate, various methoxypolyethylene glycol methacrylates, various methoxypolyethylene glycol acrylates, N
-vinyl-2-pyrrolidone, etc., and
Furthermore, vinyl acetate, glycidyl methacrylate, etc. can be introduced by copolymerization and hydrolyzed to impart hydrophilicity. Examples of ionic monomers include acrylic acid, methacrylic acid, vinyl sulfonic acid, allyl sulfonic acid, methallyl sulfonic acid, styrene sulfonate, 2-acrylamyl'-2-phenyl sulfonic acid, 2- Acrylamido-2-methyl-propanesulfonic acid, etc., and their salts, N.
N−ジメチルアミノエチルメタクリレート、N、 N−
ジエチルアミノエチルメタクリレート、N、N−ジメチ
ルアミンエチルアクリレート、N、 N−ジメチルアミ
ンプロピルメタクリルアミド、N、 N−ジメチルアミ
ンプロピルアクリルアミド等のアミン及びそれらの塩等
をあげることができる。また、各種アクリレート、メタ
クリレート、アクリルアミド、メタクリルアミド、アク
リロニトリル等を共重合により導入して、それを加水分
解してイオン性を賦与することもできる。親油性単量体
としては、たとえはN−n−ブチルアクリルアミド、N
−n−ブチルメタクリルアミド、N −tert、−ブ
チルアクリルアミド、N−tert、−ブチルメタクリ
ルアミド、N −n−ヘキシルアクリルアミド、N−n
−ヘキシルメタクリルアミド、N −n−オクチルアク
リルアミド、N−n−オクチルメタクリルアミド、N−
tert、−オクチルアクリルアミド、N−n−ドデシ
ルアクリルアミド、N −n−ドデシルメタクリルアミ
ド等のN−アルキル(メタ)アクリルアミド誘導体、N
、 N−ジグリシジルアクリルアミド、N、 N−ジグ
リシジルメタクリルアミド、N〜(4−グリシドキシブ
チル)アクリルアミド、N−(4−グリシドキシブチル
)メタクリルアミド、N−(5−グリシドキシペンチル
)アクリルアミド、N−(6−ゲリシドキシヘキシル)
アクリルアミド等のN −(w−グリシドキシアルキル
)(メタ)アクリルアミド誘導体、エチルアクリレート
、メチルメタクリレート、ブチルメタクリレート、ブチ
ルアクリレート、ラウリルアクリレート、2−エチルへ
キンルメタクリレート、グリシジルメタクリレート等の
(メタ)アクリレート誘導体、アクリロニトリル、メタ
クリロニトリル酢酸ビニル、塩化ビニル、エチレン、プ
ロピレン、ブテン等のオレフィン類、スチレン、α−メ
チルスチレン、ブタジェン、イソプレン等をあげること
ができる。N-dimethylaminoethyl methacrylate, N, N-
Examples include amines such as diethylaminoethyl methacrylate, N,N-dimethylamine ethyl acrylate, N,N-dimethylamine propylmethacrylamide, N,N-dimethylamine propyl acrylamide, and salts thereof. It is also possible to introduce various acrylates, methacrylates, acrylamide, methacrylamide, acrylonitrile, etc. by copolymerization and hydrolyze them to impart ionicity. Examples of lipophilic monomers include N-n-butylacrylamide, N-
-n-butylmethacrylamide, N-tert, -butylacrylamide, N-tert, -butylmethacrylamide, N-n-hexylacrylamide, N-n
-hexylmethacrylamide, N-n-octylacrylamide, N-n-octylmethacrylamide, N-
N-alkyl (meth)acrylamide derivatives such as tert, -octylacrylamide, N-n-dodecyl acrylamide, N-n-dodecylmethacrylamide, N
, N-diglycidyl acrylamide, N, N-diglycidyl methacrylamide, N~(4-glycidoxybutyl)acrylamide, N-(4-glycidoxybutyl)methacrylamide, N-(5-glycidoxypentyl) ) acrylamide, N-(6-gelisidoxyhexyl)
N-(w-glycidoxyalkyl)(meth)acrylamide derivatives such as acrylamide, (meth)acrylates such as ethyl acrylate, methyl methacrylate, butyl methacrylate, butyl acrylate, lauryl acrylate, 2-ethylhequinyl methacrylate, glycidyl methacrylate, etc. Examples include derivatives of acrylonitrile, methacrylonitrile, vinyl acetate, vinyl chloride, olefins such as ethylene, propylene, and butene, styrene, α-methylstyrene, butadiene, and isoprene.
次に上記した単量体の重合体を水に不溶化する方法とし
ては、重合時に不溶化する方法と重合後の処理で不溶化
する方法があるが、具体的な不溶化方法として、分子中
に少くとも二個以上の二重結合を有する架橋性モノマー
と上記した(メタ)アクリルアミド誘導体と共重合する
方法、N−アルコキシメチル(メタ)アクリルアミド誘
導体を共重合する方法、上記した親油性モノマーの比率
を高めて(メタ〕アクリルアミド誘導体と共重合する方
法、塊状で重合する方法、重合体を加熱処理する方法、
セルロース等の水に不溶の繊維状物質等と(合体を一体
化する方法、または重合体中に水酸基あるい叫アミノ基
等が存在する場合には、それらとエピクロルヒドリン等
の多官能性化合物を反応させて架橋し、不溶化する方法
、更にはカルボキシ基、スルホン酸基、水酸基等のよう
に活性水素を有する置換基の置換された単量体との共重
合もしくはそれら置換基の置換された重合体との間で複
合体を形成させ、不溶化する方法等を採用できる。Next, methods for making the above-mentioned monomer polymer insolubilized in water include a method of making it insolubilized during polymerization and a method of making it insolubilized by treatment after polymerization. A method of copolymerizing a crosslinkable monomer having 1 or more double bonds with the above-mentioned (meth)acrylamide derivative, a method of copolymerizing an N-alkoxymethyl (meth)acrylamide derivative, and a method of copolymerizing the above-mentioned lipophilic monomer by increasing the ratio of the above-mentioned lipophilic monomer. A method of copolymerizing with a (meth)acrylamide derivative, a method of polymerizing in bulk, a method of heat treating a polymer,
When a fibrous substance, etc. that is insoluble in water such as cellulose (combining method, or if there are hydroxyl groups or amino groups in the polymer, reacting them with a polyfunctional compound such as epichlorohydrin) Copolymerization with monomers substituted with substituents having active hydrogen such as carboxy groups, sulfonic acid groups, hydroxyl groups, etc., or polymers substituted with these substituents. A method such as forming a complex with and making it insolubilized can be adopted.
より具体的には第1の方法では架橋性モノマーとして、
たとえばN、N’−メチレンビスアクリルアミド、N、
N−ジアリルアクリルアミド、トリアクリルホルマー
ル、N、N−ジアクリロイルイミド、N、 N−ジメタ
クリロイルイミド、エチレングリコールアクリレート、
エチレングリコールジメタクリレート、各種ポリエチレ
ングリコールジアクリレート、各種ポリエチレングリコ
ールジメタクリレート、プロピレングリコールジアクリ
レート、プロピレングリコールジメタクリレート、各種
ポリプロピレングリコールジアクリレート、各種ポリプ
ロピレングリコールジメタクリレート、1,6−ブチレ
ングリコールジアクリレート、1,6−ブチレングリコ
ールジメタクリレート、1,4−ブチレングリコールジ
メタクリレート、グリセロールジメタクリレート、イ・
オペンチルグリコールジメタクリレート、トリメチロー
ルプロパントリアクリレート、トリメチロールエタント
リアクリレート、トリメチロールエタントリメタクリレ
ート、トリメチロールエタントリアクリレート、テトラ
メチロールメタンテトラメタクリレート、テトラメチロ
ールメタントリアクリレート、ジビニルベンゼン、ジア
リルフタレート等を使用できる。More specifically, in the first method, as a crosslinking monomer,
For example, N,N'-methylenebisacrylamide, N,
N-diallylacrylamide, triacryl formal, N,N-diacryloimide, N,N-dimethacryloimide, ethylene glycol acrylate,
Ethylene glycol dimethacrylate, various polyethylene glycol diacrylates, various polyethylene glycol dimethacrylates, propylene glycol diacrylate, propylene glycol dimethacrylate, various polypropylene glycol diacrylates, various polypropylene glycol dimethacrylates, 1,6-butylene glycol diacrylate, 1, 6-butylene glycol dimethacrylate, 1,4-butylene glycol dimethacrylate, glycerol dimethacrylate, i.
Uses opentyl glycol dimethacrylate, trimethylolpropane triacrylate, trimethylolethane triacrylate, trimethylolethane trimethacrylate, trimethylolethane triacrylate, tetramethylolmethanetetramethacrylate, tetramethylolmethane triacrylate, divinylbenzene, diallyl phthalate, etc. can.
第2の方法でのN−アルコキシメチル(メタ)アクリル
アミド誘導体としてはN−ヒドロキシメチル(メタ)ア
クリルアミドも含み、たとえばN−メチロール(メタ)
アクリルアミド、N−メトキシメチル(メタ)アクリル
アミド、N−エトキシメチル(メタ)アクリルアミド、
N−n−ブトキシメチル(メタ)アクリルアミド、N
−tert、 −ブトキシメチル(メタ)アクリルアミ
ド等を使用てきる。第6の方法での親油性モノマーのア
ンフィフィリノクな性質を有する(メタ)アクリルアミ
ド誘導体に対する比率は(メタ)アクリルアミド誘導体
と親油性モノマーとの組合せにより変化し、−概に断定
できないが、一般的には、1%以上好ましくは3%以上
である。第4の方法による塊状で重合する方法としては
、溶媒で稀釈せずにそのまま重合して重合体ブロックを
得る方法或いは溶媒に懸濁させながらモノマー筒中で重
合を行い、粒子状重合体を得る方法等を採用できる。第
5の方法である重合体を加熱処理する方法において加熱
条件は重合体により異なり一様ではないが、一般的には
、60〜250℃、好ましくは8o〜200℃の温度で
、塊状重合、懸濁重合、溶液重合等で得た重合体を加熱
処理する。その際、溶液重合においては、乾燥或いは溶
媒の留去と加熱処理を兼ねて行ってもよい。第6の方法
である繊維状物質等と一体化する方法としては、セルロ
ース、ナイロン、ポリエステル、アクリル等の繊維また
はポリプロピレン、エチレン−プロピレン共重合体等で
できた不繊布等の水に不溶の1繊維状物質あるいはシリ
カ、アルミナ、ゼオライト等の水不溶の多孔質無機物質
に上記した(メタ)アクリルアミド誘導体を含浸重合或
いはグラフト重合する方法、及び重合体を含浸させる方
法等を採用できる。第7の方法であるエピクロルヒドリ
ン等の多官能性化合物を反応させて架橋し、不溶化する
方法では重合体中に水酸基あるいはアミン基を予め導入
しておく必要がある。アミン基は共重合により容易に導
入できるが、水酸基の場合には、ヒドロキシエチルメタ
クリレート、イノプロペニルフェノール等との共重合ま
たは酢酸ビニル、グリシジルメタクリレート等を共重合
で導入して、その後塩基性物質でケン化して水酸基を導
入する方法もある。The N-alkoxymethyl (meth)acrylamide derivatives in the second method also include N-hydroxymethyl (meth)acrylamide, such as N-methylol (meth)acrylamide.
Acrylamide, N-methoxymethyl (meth)acrylamide, N-ethoxymethyl (meth)acrylamide,
N-n-butoxymethyl (meth)acrylamide, N
-tert, -butoxymethyl(meth)acrylamide, etc. can be used. The ratio of lipophilic monomer to (meth)acrylamide derivative having amphiphilic properties in the sixth method varies depending on the combination of (meth)acrylamide derivative and lipophilic monomer; The content is 1% or more, preferably 3% or more. The fourth method of bulk polymerization is a method of directly polymerizing without diluting with a solvent to obtain a polymer block, or a method of polymerizing in a monomer cylinder while suspending in a solvent to obtain a particulate polymer. etc. can be adopted. In the fifth method, which is a method of heat treating a polymer, the heating conditions vary depending on the polymer and are not uniform, but generally, bulk polymerization is carried out at a temperature of 60 to 250°C, preferably 8o to 200°C. A polymer obtained by suspension polymerization, solution polymerization, etc. is heat-treated. At this time, in the solution polymerization, drying or distillation of the solvent may be performed concurrently with heat treatment. The sixth method of integrating with fibrous materials, etc. is to use water-insoluble materials such as fibers such as cellulose, nylon, polyester, acrylic, or nonwoven fabrics made of polypropylene, ethylene-propylene copolymers, etc. A method of impregnating or graft polymerizing the above-mentioned (meth)acrylamide derivative onto a fibrous material or a water-insoluble porous inorganic material such as silica, alumina, or zeolite, a method of impregnating a polymer, etc. can be employed. In the seventh method, in which a polyfunctional compound such as epichlorohydrin is reacted to crosslink and insolubilize, it is necessary to introduce a hydroxyl group or an amine group into the polymer in advance. Amine groups can be easily introduced by copolymerization, but in the case of hydroxyl groups, they can be introduced by copolymerization with hydroxyethyl methacrylate, inopropenylphenol, etc., or by copolymerization with vinyl acetate, glycidyl methacrylate, etc., and then with a basic substance. Another method is to introduce hydroxyl groups by saponification.
ついで、前記した重合体とエビクロルヒドリ7等の多官
能性化合物とを塩基性物質の存在下に反応させて架橋し
、不溶化する。その際、水溶液そのままで不溶化すると
寒天状となり、それを破砕することにより実用に供され
る。また水溶液を油中に分散させて不溶化すると粒状ゲ
ルとなる。Next, the above-mentioned polymer and a polyfunctional compound such as shrimp chlorhydride 7 are reacted in the presence of a basic substance to crosslink and insolubilize the polymer. At that time, when the aqueous solution is insolubilized as it is, it becomes agar-like, and it is put into practical use by crushing it. Further, when an aqueous solution is dispersed in oil to make it insolubilized, it becomes a granular gel.
第8の方法は活性水素を有する前記した単量体との共重
合、それら単量体の共重合体との複合、共重合体中の活
性水素をアンモニウムイオン等で置換しておき、まず混
合しておきその後酸を添加して活性水素を賦活させて複
合体を形成させて不溶化する方法である。The eighth method is copolymerization with the above-mentioned monomers having active hydrogen, complexing with copolymers of these monomers, replacing active hydrogen in the copolymer with ammonium ions, etc., and first mixing. This is a method in which a complex is formed by adding an acid to activate the active hydrogen and make it insolubilized.
上記した8つの方法を各々単独で採用してもよいし、併
せて採用してもよい。概ね併用したほうがより効果的な
結果を得ることができる。Each of the eight methods described above may be used alone or in combination. In general, more effective results can be obtained when used together.
上記した方法に従って、本発明のセ濃縮用樹脂を製造す
るに当って採用できる重合のより具体的方法としては、
たとえば(1)モノマーを溶剤で稀釈せずにそのまま重
合して重合体ブロックを製造する方法、(2)溶剤中で
重合して重合後転′:栗或いは貧溶剤中に重合体を析出
させ重合体を得る方法、(3))跡濁重合により粒子状
重合体として得る方法、(4)乳化重合により重合体ラ
テックスとして得る方法、(5)水に不溶な1維状物質
または多孔質無機物質に重合体溶液の含浸あるいはグラ
フト重合等の方法で重合体を一体化する方法等を採用で
きる。その際、重合を開始1−る方法としては、加熱の
みによっても行い5るが、通常重合開始剤を使用したほ
うが良好な結果が得られる。重合開始剤としてはラジカ
ル重合を開始する能力を有するものであれば制限はなく
、たとえば無機過1竣化物、有機過酸化物、それらの過
φ化物と還元剤との絹合せおよびアゾ化合物などがある
。具体的には過硫酸アンモニウム、過硫酸カリ、過酸化
水素、te百−ブチルパーオキシド、ベンゾイルパーオ
キシド、クメンヒドロキシパーオキシド、1e(t−ブ
チルパーオキシ−2−エチルヘキサノエート、過安息香
酸ブチル等があり、それらと組合せる還元剤としては亜
硫酸塩、亜硫酸水素塩、鉄、銅、コバルトなどの低次の
イオン価の塩、アニリン等の有機アミン更にはアルドー
ス、ケトース等の還元糖等を挙ることができる。アゾ化
合物と(〜では、アゾビスイノブチロニトリル、2,2
′−アゾビス−2−アミジノプロパン塩酸塩、2,2′
−アゾビス−2,4−ジメチルバレロニトリル、4,4
′−アゾビス−4−シアツバレイン、唆などを使用する
ことができる。また、上記した重合開始剤の2種以上を
併用することも可能である。この場合の重合開始剤の添
加量は通常採用される量的範囲で充分てあり、たとえば
単量体当り0.01〜5重量%、好ましくは0.05−
2重量%の範囲である。More specific polymerization methods that can be adopted in producing the resin for concentration of the present invention according to the above-mentioned method include:
For example, (1) a method in which the monomer is directly polymerized without diluting it with a solvent to produce a polymer block, (2) a method in which the monomer is polymerized in a solvent and post-polymerization': a method in which the polymer is precipitated in chestnut or a poor solvent and polymerized. (3) A method of obtaining a particulate polymer by turbid polymerization, (4) A method of obtaining a polymer latex by emulsion polymerization, (5) A fibrous substance or a porous inorganic substance insoluble in water. A method of integrating the polymer by impregnation with a polymer solution or graft polymerization can be adopted. At this time, the polymerization can be started by heating alone, but better results are usually obtained by using a polymerization initiator. The polymerization initiator is not limited as long as it has the ability to initiate radical polymerization, and examples include inorganic peroxides, organic peroxides, combinations of these peroxides and reducing agents, and azo compounds. be. Specifically, ammonium persulfate, potassium persulfate, hydrogen peroxide, te-10-butyl peroxide, benzoyl peroxide, cumene hydroxy peroxide, 1e(t-butylperoxy-2-ethylhexanoate, butyl perbenzoate) Reducing agents that can be combined with these include sulfites, hydrogen sulfites, salts with low ionic valences such as iron, copper, and cobalt, organic amines such as aniline, and reducing sugars such as aldoses and ketoses. Azo compounds (in ~, azobisinobutyronitrile, 2,2
'-Azobis-2-amidinopropane hydrochloride, 2,2'
-azobis-2,4-dimethylvaleronitrile, 4,4
'-Azobis-4-cyatubarein, silica, etc. can be used. It is also possible to use two or more of the above polymerization initiators in combination. In this case, the amount of the polymerization initiator added is within a commonly used quantitative range, for example, 0.01 to 5% by weight, preferably 0.05-5% by weight, based on the monomer.
It is in the range of 2% by weight.
このようにして得られる重合体のうち、ブロック状のも
の、または溶剤を留去して得られる重合体は、粉砕によ
り粉状K、または融解して粒状、フレーク状、繊維状ま
たはフィルム状に成型し、粒子状重合体はそのままの形
で、またラテノク、ス状重合体は布および紙のような繊
維状物質に含浸コーティングしたり、またはフィルム化
して、濃縮用樹脂として提供することができる。Among the polymers obtained in this way, those in block form or the polymers obtained by distilling off the solvent can be crushed into powder K, or melted into granules, flakes, fibers, or films. Molded, particulate polymers can be provided in their raw form, and latex and sliver polymers can be impregnated and coated on fibrous materials such as cloth and paper, or formed into films to provide concentrated resins. .
上記した方法により、種々の形態の濃縮用4り4脂を製
造できるが、la@用樹脂をどのようにして使用するか
によって、その形態は適宜きまってくるので、一様には
規定できない。By the above-mentioned method, it is possible to produce various forms of concentrating 4-4 fat, but the form depends on how the la@ resin is used, so it cannot be uniformly defined.
しかし、一般的にはそれらの樹脂は粉末状もしくは粒状
で使用される場合が多い。However, these resins are generally used in powder or granule form in many cases.
粉末状品は前記したように水溶液中でゲル重合を行い、
その後乾燥粉砕して得る等積々の方法をとりうる。一方
、粒状品は一般的には懸濁重合法により容易に製造され
るのであるが、本発明で使用されるN−アルキルまたは
ト■−アルキレン置換(メタ)アクリルアミドは一般に
水溶性が高いので、懸濁重合法としては、単量体または
その水溶液等を油中に分散した逆相懸濁重合、水溶液中
に多量の電解′η等を溶解して単量体の溶解度を抑制し
て行5塩析懸濁重合、更には重合体の曇点以上の高温で
重合を行い、重合体を析出させる析出懸濁重合等の方法
が採用される。更にシリカ、アルミナ、ゼオライトのよ
うな多孔質無機質粒子表面に重合体溶液の含浸あるいは
グラフト重合等の方法で重合体と一体化したものも採用
できる。更にその際に単量体とは相溶するが、重合体と
は相溶しないような第3成分を添加して製造することに
より、多孔質の、]tf脂を製造することも可能である
。The powdered product undergoes gel polymerization in an aqueous solution as described above.
Thereafter, a number of methods can be used, such as drying and grinding. On the other hand, granular products are generally easily produced by suspension polymerization, but since the N-alkyl- or tri-alkylene-substituted (meth)acrylamide used in the present invention is generally highly water-soluble, Suspension polymerization methods include reverse-phase suspension polymerization in which a monomer or its aqueous solution is dispersed in oil, and a method in which a large amount of electrolyte, etc., is dissolved in an aqueous solution to suppress the solubility of the monomer. Methods such as salting-out suspension polymerization and further precipitation suspension polymerization in which polymerization is performed at a high temperature higher than the clouding point of the polymer to precipitate the polymer are employed. Furthermore, porous inorganic particles such as silica, alumina, and zeolite, whose surfaces are impregnated with a polymer solution or integrated with a polymer by a method such as graft polymerization, may also be used. Furthermore, it is also possible to produce porous [TF fat] by adding a third component that is compatible with the monomer but not compatible with the polymer. .
以上のようにして製造した濃縮用樹脂は固体状であり、
水溶液との接触により水を吸収保持し、大過剰の水の存
在下においても加温により収縮して放水するという極め
て特異的な仲買を有する。The concentration resin produced as described above is in a solid state,
It has a very unique ability to absorb and retain water when it comes into contact with an aqueous solution, and even in the presence of a large excess of water, it shrinks and releases water when heated.
更に都合のよいことには、上記の水の吸収・保持及び放
出という過程を繰り返すことができる。また、核剤への
水の吸収量は該樹脂の組成、温度及び水溶液の組成等に
より変化する。樹脂組成について言えは、前記した共重
合しうる単量体のうち親油性単量体と・の共重合体では
、その比率が増大すると吸水量は低下し、−万闇脂の機
械的強度は大きくなる。また、親水性もしくはイオン性
単量体との共重合体では、その比率が増大すると、吸水
量そのものは増加するが、温度による吸水量の変化は少
な(なり、機械的強度も低下する。上記したように樹脂
組成により吸水骨は変化するが、概ね常温(25°C)
においては自重の2倍から100倍程度の水を吸収でき
、温度を下げると水の吸収量を増加させることができる
。Furthermore, advantageously, the water absorption, retention and release processes described above can be repeated. Further, the amount of water absorbed by the nucleating agent changes depending on the composition of the resin, temperature, composition of the aqueous solution, etc. Regarding the resin composition, in a copolymer of lipophilic monomers among the copolymerizable monomers mentioned above, as the ratio increases, the amount of water absorbed decreases, and the mechanical strength of the growing. In addition, in copolymers with hydrophilic or ionic monomers, as the ratio increases, the water absorption itself increases, but the change in water absorption due to temperature is small (and the mechanical strength also decreases. As shown above, the water-absorbing bone changes depending on the resin composition, but generally at room temperature (25°C)
can absorb about 2 to 100 times its own weight of water, and lowering the temperature can increase the amount of water absorbed.
水溶液中に無機性塩、有機性塩、水溶性有機物質等の低
分子物質が溶解■−ている場合には、それらの物質を含
んだ水溶液のまま該樹脂に取り込むことができる。無1
幾性塩の溶存する場合、従来の吸水樹脂ではその吸水量
は急激に減少し、たとえばメチレンビスアクリルアミド
で架橋したアクリルアミド−アクリル酸ナトリウム共重
合体(アクリル酸す) IJウム含量:21重量%)で
は、蒸留水中と1規定塩化ナトリウム水溶液中とでその
吸水水量に及ぼす共存塩の影響は小いと結論できる。When low-molecular substances such as inorganic salts, organic salts, and water-soluble organic substances are dissolved in the aqueous solution, the aqueous solution containing these substances can be incorporated into the resin as is. No 1
When geometric salts are dissolved, the amount of water absorbed by conventional water-absorbing resins decreases rapidly. Therefore, it can be concluded that the effect of coexisting salts on the amount of water absorbed in distilled water and 1N aqueous sodium chloride solution is small.
また、共存塩の種類によっては、たとえば塩化カルシウ
ムでは吸水骨が逆に増加するという結果も得られている
。Furthermore, depending on the type of coexisting salt, for example, calcium chloride has been found to increase water-absorbing bone.
上記したように本発明の濃縮用樹脂は溶質の分子量に応
じて吸水時にゲル中に取り込む場合と排除する場合の2
2のケースが存在し、該濃縮用樹脂は分子量分画能を有
しており、その分画分子量は樹脂の組成及び温度により
変化する。一般に不溶化の割合、例えば架橋度等が低い
とか、親水性もしく1・まイオン性単量体との共重合体
であるとかで、吸水量が比較的大きい場合には、分画分
子量は大きくなる。一方、架橋度等が高(・とが、親油
性単量体との共重合体であるとかで、吸水量が比較的小
さい場合には、分画分子量は小さくなる。As mentioned above, the concentration resin of the present invention can be incorporated into the gel during water absorption or excluded depending on the molecular weight of the solute.
There are two cases in which the concentration resin has a molecular weight fractionation ability, and the molecular weight fraction changes depending on the composition and temperature of the resin. Generally, if the water absorption is relatively large due to a low insolubilization rate, such as a low degree of crosslinking, or a copolymer with a hydrophilic or ionic monomer, the molecular weight cut-off will be large. Become. On the other hand, if the degree of crosslinking is high (such as when the polymer is a copolymer with a lipophilic monomer and the amount of water absorbed is relatively small), the molecular weight cutoff will be small.
分画分子量の具体的な値については、樹脂の組成、温度
及び水溶液の組成更には濃縮物質の種類により大きく変
化するので、一様には述べられないか、例えば常温付近
でのポU N−アクリロイルピロリジンをメチレンビス
アクリルアミドで架橋した樹脂による、水溶液中で分子
鎖の比較的拡がった形態をとるポリエチレングリコール
の濃縮におX7・ては、その分画分子量は1.000の
オーダーにある。一方、テキストラン、タン・ζ■り等
の水溶液中でコンパクトな構造をとるものて71マ、そ
の分画分子量はio、oooのオーダーに存在する。ま
た、分画分子骨は当然一義的に決められるのではなく、
分布を持ったものになる。The specific value of the molecular weight fraction cannot be stated uniformly because it varies greatly depending on the composition of the resin, the temperature, the composition of the aqueous solution, and the type of concentrated substance. When concentrating polyethylene glycol with a relatively expanded molecular chain in an aqueous solution using a resin in which acryloylpyrrolidine is crosslinked with methylenebisacrylamide, the molecular weight cutoff is on the order of 1.000. On the other hand, there are compounds that have a compact structure in aqueous solutions such as text run, tanning, and zeolization, and their molecular weight fractions exist on the order of io and ooo. In addition, the fractionated molecular bone is of course not uniquely determined;
It becomes something with a distribution.
また、吸水した該樹脂の温度を上げてゆ(と、樹脂は収
縮して水を放出する。更に温度を上げてゆくとある温度
以上では加温しても樹脂の収縮が極めて緩慢になり、転
移点の観察されることがある。その転移温度は樹脂の組
成により決まり、概ね1o−ioooCの範囲で制御で
きろ。その転移温度付近の樹脂の収縮量は樹脂の組成及
び水溶液の組成等により変化するが、概ね自重の1倍よ
り20倍程度である。上記した如く、樹脂の加熱・冷却
を繰り返して水の分離及び保持を行うのであるが、その
時の樹脂の吸水温度範囲は、一般的には0〜100°C
である。一方、吸水した。、fI脂を加熱して収縮させ
るには、液状の水でも気体状の水でもよく、その温度は
この樹脂の使用目的により異なるが、一般的には10−
200℃である。In addition, when the temperature of the resin that has absorbed water is increased, the resin contracts and releases water.As the temperature is further increased, the contraction of the resin becomes extremely slow even when heated above a certain temperature. A transition point may be observed.The transition temperature is determined by the composition of the resin and can be controlled within the range of approximately 1o-ioooC.The amount of shrinkage of the resin near the transition temperature depends on the composition of the resin, the composition of the aqueous solution, etc. Although it varies, it is generally between 1 and 20 times its own weight.As mentioned above, the resin is repeatedly heated and cooled to separate and retain water, but the temperature range at which the resin absorbs water at that time is generally 0~100°C
It is. On the other hand, it absorbed water. To heat and shrink fI fat, liquid water or gaseous water may be used, and the temperature varies depending on the purpose of use of the resin, but is generally 10-
The temperature is 200°C.
濃縮の具体的方法としては、該樹脂を濃縮しようとする
水溶液に接触させて水を吸収させ、吸水した樹脂をその
水溶液より分離し、分離した樹脂をより高温の雰囲気下
におき、水を放出させることにより行うことが可能であ
り、この一連の操作をくり返すことによって多量の水溶
液を濃縮することができる。この時、水溶液中に低分子
物質が共存1−る場合には、低分子物質は横締されずに
、高分子物質のみが濃縮される。A specific method for concentrating is to bring the resin into contact with an aqueous solution to be concentrated to absorb water, separate the absorbed resin from the aqueous solution, and place the separated resin in a higher temperature atmosphere to release water. By repeating this series of operations, a large amount of aqueous solution can be concentrated. At this time, if a low molecular weight substance coexists in the aqueous solution, only the high molecular weight substance is concentrated without the low molecular weight substance being laterally tightened.
基本的な実施態様としては、まず粉状、フレーク状、ビ
ーズ状、繊維状、フィルム状の濃縮用樹脂な(濃縮すべ
き水溶液と接触させて該樹脂に水を吸収させ、その後膣
樹脂を水溶液と分離する手段が採られる。吸水及びその
後の分離の具体的方法としては、゛該水溶液に直接添加
して吸水させ、その後沈降、濾過、遠・し分離等の方法
で分離を行う方法、予め核剤を水溶液と隔離できるよう
なもの、たとえば袋状のようなものに入れそれを水溶液
と接触させて水を吸収させて分離する方法、繊維状また
は平織等に加工した布状の該樹脂を水溶液中に浸漬して
吸水させ、その後引き上げる等の方法が採用できる。ま
た、上記の操作を多段にわたって行ってもよい。その際
、なるべ(低温で吸水させたほうが吸水骨を太き(でき
都合がよい。In a basic embodiment, a concentrating resin in the form of powder, flakes, beads, fibers, or film is first brought into contact with the aqueous solution to be concentrated to absorb water, and then the vaginal resin is dissolved in the aqueous solution. Specific methods for water absorption and subsequent separation include: ``Directly adding water to the aqueous solution to absorb water, and then separating by sedimentation, filtration, centrifugal separation, etc.; A method in which the nucleating agent is placed in something that can isolate it from the aqueous solution, such as a bag, and brought into contact with the aqueous solution to absorb water and separate the resin; Methods such as immersing in an aqueous solution to absorb water and then pulling it up can be adopted.Also, the above operation may be performed in multiple stages. convenient.
斯(して水を吸収した樹脂を高温の雰囲気において水を
放出させる方法としては、高温水中に浸漬する方法、ス
チームの如き加熱気体を吹きつける方法、乾燥機の如き
高温の空気中に放置する方法などを採用できる。また、
繰り返して使用する場合には、水切りをよくしておいた
ほうが、その後の水の分離効率を高める上で効果的であ
る。Methods for releasing water from the resin that has absorbed water in a high-temperature atmosphere include immersing it in high-temperature water, blowing heated gas such as steam, and leaving it in high-temperature air such as in a dryer. methods etc. can be adopted.Also,
When using repeatedly, it is effective to drain the water well in order to increase the subsequent water separation efficiency.
作用:
本発明の濃縮用樹脂の具体的応用例としては各種水浴液
の接縮、特に蒸発法などでは供線の困難な食品、アミノ
酸、たんぽ(質、多糖類、酵素、抗生物質、エマルショ
ン菌体等の熱により変質しやすい物質を含有する水溶液
の濃縮及び結果としては晶析等があげられる。Function: Examples of specific applications of the concentrating resin of the present invention include condensation of various water bath liquids, foods, amino acids, dandelions, polysaccharides, enzymes, antibiotics, and emulsion bacteria, which are difficult to use with evaporation methods. Concentration of aqueous solutions containing substances that are easily altered by body heat, etc. and crystallization as a result can be mentioned.
本発明の舗縮用何脂は、温度変化による膨潤・収≦4特
性を利用して容易に再生することが可能であり、無機塩
の共存下でも、吸水骨の低下は少く、水を吸収した後の
形態保持性は曳好であるなどの優れた特性を有している
ので次のような効果を有している。すなわち、第一に蒸
発・凍結等の相の変化を利用する水の分離ではないので
、低エイ・ルギーコストで水の分離が可能であり、かつ
必ずしも大規模な装置を必要とせず、任意の場所に設置
することが可能である。第二に、低温はど水の分14#
容量が大きくなるので、加熱により変質を起しやすい物
質を含む水溶液の譲縮或いは晶析等に極めて有効である
。第三に、酵素、多糖−1たんばく質、抗生物′6等緩
衝剤の共存する水溶液では、緩衝剤となる電解質は濃縮
せずにそのままの濃度で、たんばく質等の高分子物質の
みを濃縮できる等の効果を有する。The paving fat of the present invention can be easily regenerated by utilizing the characteristics of swelling and absorption ≦4 due to temperature changes, and even in the coexistence of inorganic salts, the water absorption bone decreases little and it absorbs water. It has excellent properties such as good shape retention after drying, and has the following effects. In other words, first of all, since water separation does not utilize phase changes such as evaporation or freezing, water separation is possible at low energy and energy costs, and does not necessarily require large-scale equipment. It is possible to install it anywhere. Second, at low temperatures, the amount of water is 14#
Since the capacity is large, it is extremely effective for condensation or crystallization of aqueous solutions containing substances that are easily altered by heating. Third, in an aqueous solution in which buffering agents such as enzymes, polysaccharide-1 proteins, and antibiotics 6 coexist, the electrolyte serving as the buffering agent is not concentrated, but remains at its original concentration, and only polymeric substances such as proteins are present. It has the effect of being able to concentrate.
以下本発明を実施例により更に説明する。The present invention will be further explained below with reference to Examples.
実施例1
N−アクリロイルピロリジン50’ 7.59とN、
N’−メチレンビスアクリルアミド267とを水1.1
70fに溶解し0.5wt%のN、 N−メチレンビス
アクリルアミドを含むN−アクリロイルピロリジンの水
溶液を調製した。該水溶液を10℃に冷却した後、2t
のステンレス製ジーワー瓶に移液し、1t/=の流量で
ボールフィルターを用いて窒素ガスを1時間バブリング
した。ついで該水溶液に過硫酸アンモニウム2552を
水1olPに溶解した液と亜硫酸水素ナトリウム116
2を水10グに溶解し1こ液とを同時に添加し、該水溶
液を断熱的に重合した。Example 1 N-acryloylpyrrolidine 50' 7.59 and N,
N'-methylenebisacrylamide 267 and water 1.1
An aqueous solution of N-acryloylpyrrolidine containing 0.5 wt% N,N-methylenebisacrylamide dissolved in 70f was prepared. After cooling the aqueous solution to 10°C, 2t
The solution was transferred to a stainless steel Ziwer bottle, and nitrogen gas was bubbled through it for 1 hour using a ball filter at a flow rate of 1 t/=. Next, a solution prepared by dissolving ammonium persulfate 2552 in water 1olP and sodium bisulfite 116 were added to the aqueous solution.
2 was dissolved in 10 g of water, and 1 solution was added at the same time, and the aqueous solution was polymerized adiabatically.
得られたゲルを細断して乾燥した後、更に粉砕して20
〜100メツシ一留分を採取し、サンプルとした。0.
52の該サンプル粉末を05%の牛血清アルブミン水溶
M20艷に添加し所定温度で1時間攪拌した後、5分間
静置し、その上澄液の254 nmでの吸光度を測定す
る事により該上澄液のl浸度を算出した。各温ル:での
上澄液の濃度は、30℃で071%、15℃で078%
、5℃で086%であった。また測定前後のサンプル粉
末を顕微鏡で観察したところ、温度変化およびイイ拌に
よるサンプル粉末の破砕等は生じていなかった。The obtained gel was shredded, dried, and further crushed to give 20
A fraction of ~100 meth was collected and used as a sample. 0.
The sample powder of No. 52 was added to 0.5% bovine serum albumin aqueous solution M20, stirred for 1 hour at a specified temperature, left to stand for 5 minutes, and the absorbance of the supernatant liquid was measured at 254 nm. The immersion degree of the clear liquid was calculated. The concentration of the supernatant at each temperature is 0.71% at 30°C and 0.78% at 15°C.
, 086% at 5°C. Furthermore, when the sample powder was observed under a microscope before and after the measurement, it was found that the sample powder was not crushed due to temperature changes or stirring.
実施例2
0.5wt%のN、 N−メチレンビスアクリルアミド
を含むN−n−プロピルアクリルアミドの60%水溶液
を用いて、実施例1と同様の方法によりサンプル粉末を
得た。該サンプル粉末062と0.5%の牛血清アルブ
ミン水溶液20rn1.を用いて、実施例1と同様の方
法により各温度での牛血清アルブミン水晶液の濃度を測
定し1こところ、30℃で0.63%、15℃で070
%、5℃で084%であった。Example 2 A sample powder was obtained in the same manner as in Example 1 using a 60% aqueous solution of Nn-propylacrylamide containing 0.5 wt% of N, N-methylenebisacrylamide. The sample powder 062 and 0.5% bovine serum albumin aqueous solution 20rn1. Using the same method as in Example 1, the concentration of bovine serum albumin crystal liquid was measured at each temperature.
%, and 0.84% at 5°C.
実施例6
4、7 wt%の2−アクリルアミド−2−フェニルプ
ロパンスルホン酸ナトリウムを含むN−アクリロイルピ
ロリジン水溶液を芒硝等を用いて塩析懸濁重合した後、
得られたゲル粒子を乾燥してサンプルとした。15℃で
市販の牛乳ろ02に該サンプル粒子052を添加して攪
拌後、戸別した。F液は182得られ、127の水を脱
水できた。Example 6 After salting out and suspension polymerizing an aqueous N-acryloylpyrrolidine solution containing 4 and 7 wt% of sodium 2-acrylamido-2-phenylpropanesulfonate using Glauber's salt etc.
The obtained gel particles were dried and used as a sample. The sample particles 052 were added to a commercially available milk filter 02 at 15°C, stirred, and then distributed from house to house. 182 pieces of liquid F were obtained, and 127 pieces of water could be dehydrated.
実施例4
濃度43%のSBRラテックス(三井東圧化学■製、ポ
リラック755)50fに実施例6で得たサンプル粒子
0.5ii’を室温で添加して攪拌した。十分攪拌した
後戸別して涙液の濃度を測定したところ52%であった
。Example 4 0.5ii' of the sample particles obtained in Example 6 were added to 50f of SBR latex (manufactured by Mitsui Toatsu Kagaku, Polylac 755) with a concentration of 43% at room temperature and stirred. After thorough stirring, the concentration of tear fluid was measured at each house and found to be 52%.
実施例5〜12
実施例1で得たサンプル粉末052を表−1に示した分
子量のポリエチレングリコールの05%水溶液20m1
に添加し所定温度で1時間攪拌した後、5分間静置し、
その上澄液の屈折率を測定する事により該上澄液の濃度
を算出し、表−1に示す結果を得た。Examples 5 to 12 Sample powder 052 obtained in Example 1 was added to 20 ml of a 05% aqueous solution of polyethylene glycol having the molecular weight shown in Table 1.
After stirring at the specified temperature for 1 hour, let stand for 5 minutes,
The concentration of the supernatant was calculated by measuring the refractive index of the supernatant, and the results shown in Table 1 were obtained.
実施例13〜17
実施例2で得たサンプル粉末062と表−2に示した分
子量のポリエチレングリコールの05%水溶液20−を
用いて実施例5と同様の方法により上澄液の濃度を測定
し、表−2に示す結果を得た。Examples 13 to 17 The concentration of the supernatant liquid was measured in the same manner as in Example 5 using the sample powder 062 obtained in Example 2 and 05% aqueous solution 20 of polyethylene glycol having the molecular weight shown in Table 2. The results shown in Table 2 were obtained.
実施例18〜22
実施例ろで得たサンプル粒子0.25 fと表−6に示
した分子量のポリエチレングリコールの0,5%水溶液
20−を用いて実施例5と同様の方法により上澄液の濃
度を測定し表−3に示す結果を得た。Examples 18 to 22 A supernatant liquid was prepared in the same manner as in Example 5 using 0.25 f of sample particles obtained in the example filter and 20 mm of a 0.5% aqueous solution of polyethylene glycol having the molecular weight shown in Table 6. The concentration was measured and the results shown in Table 3 were obtained.
表−1
表−2
実施例23〜27
実施例1で得たサンプル粉末052と表−4に示した分
子量のデキストランの0.5%水溶液20mを用いて実
施例5と同様の方法により上澄液の濃度を測定し表−4
に示す結果を得た。Table 1 Table 2 Examples 23 to 27 Supernatant was prepared in the same manner as in Example 5 using the sample powder 052 obtained in Example 1 and 20 m of a 0.5% aqueous solution of dextran having the molecular weight shown in Table 4. Measure the concentration of the liquid and Table 4
The results shown are obtained.
実施例28〜32
実施例2で得たサンプル粉末0.61と表−5に示した
分子量のデキストランの05%水溶液20rnlを用い
て実施例5と同様の方法により上1q液の濃度を測定し
表−5に示す結果を得た。Examples 28 to 32 The concentration of the upper 1 q solution was measured in the same manner as in Example 5 using 0.61 of the sample powder obtained in Example 2 and 20 rnl of a 05% aqueous solution of dextran with the molecular weight shown in Table 5. The results shown in Table 5 were obtained.
実施例36・〜36
実施例6で得られたサンプル粒子0252と表−6に示
した分子量のデキストランの0.5%水溶液20#+7
!を用いて実施例5と同様の方法により上澄液の議席を
測定し表−6に示す結果を得た。Examples 36-36 Sample particles 0252 obtained in Example 6 and 0.5% aqueous solution of dextran with the molecular weight shown in Table 6 20#+7
! The surface area of the supernatant liquid was measured using the same method as in Example 5, and the results shown in Table 6 were obtained.
表−6
表−4
表−5
表−6
実施例37〜41
実施例1で得たサンプル粉末0052と表−7に示した
分子量のたんばく質の05%水溶液2rnlを用いて実
施例1と同様の方法により上澄液の濃度を測定し表−7
に示す結果を得た。Table-6 Table-4 Table-5 Table-6 Examples 37 to 41 Example 1 was prepared using sample powder 0052 obtained in Example 1 and 2rnl of a 05% aqueous solution of a protein having the molecular weight shown in Table 7. The concentration of the supernatant was measured using the same method and Table 7
The results shown are obtained.
実施例42〜46
実施例2で得たサンプル粉末0062と表−8に示した
分子量のたんばく質の05%水溶液2m7を用いて実施
例1と同様の方法により上澄液の濃度を測定し表−8に
示す結果を得た。Examples 42 to 46 The concentration of the supernatant liquid was measured in the same manner as in Example 1 using the sample powder 0062 obtained in Example 2 and 2 m7 of a 05% aqueous solution of a protein with the molecular weight shown in Table 8. The results shown in Table 8 were obtained.
表−7
表−8
手 続 補 正 書
昭和60年休月30日
特許庁長官 志 賀 学 殿
1事件の表示
昭和59年特許願第106464号
2発明の名称
濃縮用樹脂
6補正をする者
事件との関係 特許出願人
住 所 東京都千代田区霞が関三丁目2番5号4゜補正
により増加する発明の数
明細書の「発明の詳細な説明」の欄
6、補正の内容
明細書の第31頁1[−8Jのあとに次の実施例例を加
入する。Table-7 Table-8 Procedures Amendment Written by Manabu Shiga, Commissioner of the Patent Office, dated 30th month, 1985. 1. Display of the case. 1984 Patent Application No. 106464. 2. Name of the invention. Concentrating resin. 6. Case of person making an amendment. Relationship with Patent Applicant Address: 3-2-5 Kasumigaseki, Chiyoda-ku, Tokyo 4゜Number of Inventions Increased by Amendment Column 6 of “Detailed Description of the Invention” of the Specification, No. 31 of the Specification of Contents of the Amendment Add the following example after page 1 [-8J.
「実施例47
0.5wt%のN、N′−メチレンビスアクリルアミド
を含むN−イソプロピルアクリルアミドの60%水溶液
を用いて、実施例1と同様の方法によりサンプル粉末を
得た。該サンプル粉末052を15°Cで市販の牛乳6
02に添加して攪拌後、F別した。Example 47 A sample powder was obtained in the same manner as in Example 1 using a 60% aqueous solution of N-isopropylacrylamide containing 0.5 wt% of N,N'-methylenebisacrylamide. Commercially available milk at 15°C6
After adding to 02 and stirring, it was separated into F.
p液は242得られ、6fの水を脱水することができた
。242 ml of p liquid was obtained, and 6 f of water could be dehydrated.
実施例48
0.5wt%のN、 N’−メチレンビスアクリルアミ
ドを含むN、 N−ジエチルアクリルアミドの30%N
。Example 48 0.5 wt% N, N with N'-methylenebisacrylamide, 30% N in N-diethylacrylamide
.
N−ジメチルホルムアミド溶液をジュワ瓶に移液し、液
を窒素置換した後、30℃にてアゾビスインブチロニト
リルを1.5%添加して、断熱的に重合した。The N-dimethylformamide solution was transferred to a dewar bottle, and after the liquid was purged with nitrogen, 1.5% azobisin butyronitrile was added at 30°C, and polymerization was carried out adiabatically.
得られたゲルを細断して120℃で乾燥後、更に粉砕し
て20〜100メツシュ留分を採取し、サンプルとした
。該サンプル粉末052を濃度43%のSBRラテック
ス(三井東圧化学■製、商品名、ポリラック755)5
0fに室温で添加して攪拌した。十分に攪拌した後F別
してろ液の濃度を測定したところ45%であった。The resulting gel was cut into pieces, dried at 120°C, and further ground to collect 20 to 100 mesh fractions, which were used as samples. The sample powder 052 was mixed with SBR latex (manufactured by Mitsui Toatsu Chemicals, trade name, Polylac 755) with a concentration of 43%.
0f at room temperature and stirred. After thorough stirring, the concentration of the filtrate was measured by F separation and found to be 45%.
実施例49
05%のN、 N−メチレンビスアクリルアミドを含む
N−アクリロイルモルホリンの30%水溶液を用いて、
実施例1と同様の方法によりサンプル粉末を得た。該サ
ンプル粉末0.5fを濃度43%の5BI(ラテックス
(三井東圧化学■製、商品名、ポリラック755)50
fに室温で添加して攪拌した。十分に攪拌した後戸別し
てF液の濃度を測定したところ50%であった。」
特許出願人
三井東圧化学株式会社Example 49 Using a 30% aqueous solution of N-acryloylmorpholine containing 05% N, N-methylenebisacrylamide,
A sample powder was obtained in the same manner as in Example 1. 0.5f of the sample powder was mixed with 5BI (latex (manufactured by Mitsui Toatsu Chemicals, trade name, Polylac 755) at a concentration of 43%)
f and stirred at room temperature. After thorough stirring, the concentration of Solution F was measured at each door and found to be 50%. ” Patent applicant Mitsui Toatsu Chemical Co., Ltd.
Claims (1)
一般式 (上式でR1は水素原子またはメチル基、R2は水素原
子、メチル基またはエチル基、R8はメチル基、エチル
基またはプロピル基を表わす。)一般式 (上式でR1は水素原子またはメチル基、Aは+CI−
I、、−4でnは4〜6または+CH2+20 + C
H2+1を表わす。)N−アルキルまたはN−アルキレ
ン置換(メタ)アクリルアミドの単独または共重合体、
もしくは他の共重合しうる単量体との共重合体を水に不
溶化してなる濃縮用樹脂。(1) General formula (1) or general formula (Ill) (in the above formula, R1 is a hydrogen atom or a methyl group, R2 is a hydrogen atom, a methyl group, or an ethyl group, and R8 is a methyl group, an ethyl group, or a propyl group) represents a group.) General formula (In the above formula, R1 is a hydrogen atom or a methyl group, A is +CI-
I,, -4 and n is 4 to 6 or +CH2+20 + C
Represents H2+1. ) N-alkyl- or N-alkylene-substituted (meth)acrylamide homo or copolymers;
Or a concentration resin made by making a copolymer with other copolymerizable monomers insoluble in water.
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10646484A JPS60250014A (en) | 1984-05-28 | 1984-05-28 | Concentrating resin |
| CH5004/84A CH665565A5 (en) | 1983-10-22 | 1984-10-18 | METHOD FOR CONTROLLING THE CONCENTRATION OF AN AQUEOUS SOLUTION OR EMULSION CONTAINING A MACROMOLECULAR CONNECTION. |
| IT23252/84A IT1177015B (en) | 1983-10-22 | 1984-10-19 | WATER SEPARATION AGENT |
| DE19843438432 DE3438432A1 (en) | 1983-10-22 | 1984-10-19 | WATER SEPARATOR |
| CA000465979A CA1247015A (en) | 1983-10-22 | 1984-10-19 | Water-separating agent |
| FR848416134A FR2553678B1 (en) | 1983-10-22 | 1984-10-22 | WATER SEPARATING AGENT BASED ON RESIN ACRYLAMIDE OR METHACRYLAMIDE N-ALCOYL- OR N-ALKALENE SUBSTITUTED |
| GB08426658A GB2149803B (en) | 1983-10-22 | 1984-10-22 | Water-separating agent |
| KR1019840006559A KR880000108B1 (en) | 1983-10-22 | 1984-10-22 | The controlling method of water concentration in water-containing system |
| NL8403204A NL8403204A (en) | 1983-10-22 | 1984-10-22 | WATER SEPARATOR. |
| US07/076,983 US4828710A (en) | 1983-10-22 | 1987-07-21 | Method for the extraction of water from macromolecular solutions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10646484A JPS60250014A (en) | 1984-05-28 | 1984-05-28 | Concentrating resin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60250014A true JPS60250014A (en) | 1985-12-10 |
| JPH0577453B2 JPH0577453B2 (en) | 1993-10-26 |
Family
ID=14434283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10646484A Granted JPS60250014A (en) | 1983-10-22 | 1984-05-28 | Concentrating resin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60250014A (en) |
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02311506A (en) * | 1989-05-29 | 1990-12-27 | Kyoritsu Yuki Co Ltd | Water-absorbing resin for concentrating body fluid, and its preparation and use |
| JPH09509432A (en) * | 1994-12-07 | 1997-09-22 | プラズマシール・コーポレーシヨン | Plasma concentrate and tissue sealant composition |
| JP2002249523A (en) * | 2001-02-26 | 2002-09-06 | Toyobo Co Ltd | Carrier for protein purification, method for producing the same, and method for purifying protein using the same |
| US7374678B2 (en) | 2002-05-24 | 2008-05-20 | Biomet Biologics, Inc. | Apparatus and method for separating and concentrating fluids containing multiple components |
| US7470371B2 (en) | 2002-05-03 | 2008-12-30 | Hanuman Llc | Methods and apparatus for isolating platelets from blood |
| US7824559B2 (en) | 2005-02-07 | 2010-11-02 | Hanumann, LLC | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US7866485B2 (en) | 2005-02-07 | 2011-01-11 | Hanuman, Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US7987995B2 (en) | 2005-02-07 | 2011-08-02 | Hanuman, Llc | Method and apparatus for preparing platelet rich plasma and concentrates thereof |
| US8012077B2 (en) | 2008-05-23 | 2011-09-06 | Biomet Biologics, Llc | Blood separating device |
| US8048321B2 (en) | 2002-05-24 | 2011-11-01 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US8062534B2 (en) | 2002-05-24 | 2011-11-22 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
| US8313954B2 (en) | 2009-04-03 | 2012-11-20 | Biomet Biologics, Llc | All-in-one means of separating blood components |
| US8328024B2 (en) | 2007-04-12 | 2012-12-11 | Hanuman, Llc | Buoy suspension fractionation system |
| US8801586B2 (en) | 2008-02-29 | 2014-08-12 | Biomet Biologics, Llc | System and process for separating a material |
| US9011800B2 (en) | 2009-07-16 | 2015-04-21 | Biomet Biologics, Llc | Method and apparatus for separating biological materials |
| US9138664B2 (en) | 2007-04-12 | 2015-09-22 | Biomet Biologics, Llc | Buoy fractionation system |
| US9239276B2 (en) | 2011-04-19 | 2016-01-19 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9533090B2 (en) | 2010-04-12 | 2017-01-03 | Biomet Biologics, Llc | Method and apparatus for separating a material |
| US9556243B2 (en) | 2013-03-15 | 2017-01-31 | Biomet Biologies, LLC | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| US9642956B2 (en) | 2012-08-27 | 2017-05-09 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9701728B2 (en) | 2008-02-27 | 2017-07-11 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
| US9713810B2 (en) | 2015-03-30 | 2017-07-25 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| US9757721B2 (en) | 2015-05-11 | 2017-09-12 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| US9897589B2 (en) | 2002-05-24 | 2018-02-20 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
| US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
| US10183042B2 (en) | 2002-05-24 | 2019-01-22 | Biomet Manufacturing, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US10576130B2 (en) | 2013-03-15 | 2020-03-03 | Biomet Manufacturing, Llc | Treatment of collagen defects using protein solutions |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5483085A (en) * | 1977-12-14 | 1979-07-02 | Nitto Chem Ind Co Ltd | Preparation of acrylamide polymer |
| JPS5499188A (en) * | 1978-01-23 | 1979-08-04 | Kitani Kazumasa | Swellable water retention agent and manufacture therefor |
-
1984
- 1984-05-28 JP JP10646484A patent/JPS60250014A/en active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5483085A (en) * | 1977-12-14 | 1979-07-02 | Nitto Chem Ind Co Ltd | Preparation of acrylamide polymer |
| JPS5499188A (en) * | 1978-01-23 | 1979-08-04 | Kitani Kazumasa | Swellable water retention agent and manufacture therefor |
Cited By (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02311506A (en) * | 1989-05-29 | 1990-12-27 | Kyoritsu Yuki Co Ltd | Water-absorbing resin for concentrating body fluid, and its preparation and use |
| JPH09509432A (en) * | 1994-12-07 | 1997-09-22 | プラズマシール・コーポレーシヨン | Plasma concentrate and tissue sealant composition |
| JP2002249523A (en) * | 2001-02-26 | 2002-09-06 | Toyobo Co Ltd | Carrier for protein purification, method for producing the same, and method for purifying protein using the same |
| US8187477B2 (en) | 2002-05-03 | 2012-05-29 | Hanuman, Llc | Methods and apparatus for isolating platelets from blood |
| US7470371B2 (en) | 2002-05-03 | 2008-12-30 | Hanuman Llc | Methods and apparatus for isolating platelets from blood |
| US8950586B2 (en) | 2002-05-03 | 2015-02-10 | Hanuman Llc | Methods and apparatus for isolating platelets from blood |
| US9897589B2 (en) | 2002-05-24 | 2018-02-20 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US7374678B2 (en) | 2002-05-24 | 2008-05-20 | Biomet Biologics, Inc. | Apparatus and method for separating and concentrating fluids containing multiple components |
| US10183042B2 (en) | 2002-05-24 | 2019-01-22 | Biomet Manufacturing, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US8048321B2 (en) | 2002-05-24 | 2011-11-01 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US8062534B2 (en) | 2002-05-24 | 2011-11-22 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US10393728B2 (en) | 2002-05-24 | 2019-08-27 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9114334B2 (en) | 2002-05-24 | 2015-08-25 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US8163184B2 (en) | 2002-05-24 | 2012-04-24 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US7824559B2 (en) | 2005-02-07 | 2010-11-02 | Hanumann, LLC | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US8105495B2 (en) | 2005-02-07 | 2012-01-31 | Hanuman, Llc | Method for preparing platelet rich plasma and concentrates thereof |
| US8096422B2 (en) | 2005-02-07 | 2012-01-17 | Hanuman Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US7987995B2 (en) | 2005-02-07 | 2011-08-02 | Hanuman, Llc | Method and apparatus for preparing platelet rich plasma and concentrates thereof |
| US7866485B2 (en) | 2005-02-07 | 2011-01-11 | Hanuman, Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US9138664B2 (en) | 2007-04-12 | 2015-09-22 | Biomet Biologics, Llc | Buoy fractionation system |
| US8328024B2 (en) | 2007-04-12 | 2012-12-11 | Hanuman, Llc | Buoy suspension fractionation system |
| US9649579B2 (en) | 2007-04-12 | 2017-05-16 | Hanuman Llc | Buoy suspension fractionation system |
| US11725031B2 (en) | 2008-02-27 | 2023-08-15 | Biomet Manufacturing, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
| US10400017B2 (en) | 2008-02-27 | 2019-09-03 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
| US9701728B2 (en) | 2008-02-27 | 2017-07-11 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
| US8801586B2 (en) | 2008-02-29 | 2014-08-12 | Biomet Biologics, Llc | System and process for separating a material |
| US9719063B2 (en) | 2008-02-29 | 2017-08-01 | Biomet Biologics, Llc | System and process for separating a material |
| US8012077B2 (en) | 2008-05-23 | 2011-09-06 | Biomet Biologics, Llc | Blood separating device |
| US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
| US8992862B2 (en) | 2009-04-03 | 2015-03-31 | Biomet Biologics, Llc | All-in-one means of separating blood components |
| US8313954B2 (en) | 2009-04-03 | 2012-11-20 | Biomet Biologics, Llc | All-in-one means of separating blood components |
| US9011800B2 (en) | 2009-07-16 | 2015-04-21 | Biomet Biologics, Llc | Method and apparatus for separating biological materials |
| US9533090B2 (en) | 2010-04-12 | 2017-01-03 | Biomet Biologics, Llc | Method and apparatus for separating a material |
| US9239276B2 (en) | 2011-04-19 | 2016-01-19 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9642956B2 (en) | 2012-08-27 | 2017-05-09 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
| US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
| US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| US9556243B2 (en) | 2013-03-15 | 2017-01-31 | Biomet Biologies, LLC | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| US10441634B2 (en) | 2013-03-15 | 2019-10-15 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| US10576130B2 (en) | 2013-03-15 | 2020-03-03 | Biomet Manufacturing, Llc | Treatment of collagen defects using protein solutions |
| US11957733B2 (en) | 2013-03-15 | 2024-04-16 | Biomet Manufacturing, Llc | Treatment of collagen defects using protein solutions |
| US9713810B2 (en) | 2015-03-30 | 2017-07-25 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| US9757721B2 (en) | 2015-05-11 | 2017-09-12 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0577453B2 (en) | 1993-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS60250014A (en) | Concentrating resin | |
| KR880000108B1 (en) | The controlling method of water concentration in water-containing system | |
| US4279795A (en) | Hydrophilic-hydrophobic graft copolymers for self-reinforcing hydrogels | |
| Okano et al. | Temperature-responsive poly (N-isopropylacrylamide) as a modulator for alteration of hydrophilic/hydrophobic surface properties to control activation/inactivation of platelets | |
| US4107121A (en) | Ionogenic hydrophilic water-insoluble gels from partially hydrolyzed acrylonitrile polymers and copolymers, and a method of manufacturing same | |
| Ghazinezhad et al. | A review of frontal polymerization in the chemical industry. | |
| CA1279307C (en) | High molecular composite material | |
| Takei et al. | Temperature-modulated platelet and lymphocyte interactions with poly (N-isopropylacrylamide)-grafted surfaces | |
| CN109971001B (en) | A kind of macroporous thermosensitive amphiphilic hydrogel material and preparation method thereof | |
| Yancheva et al. | Polyelectrolyte Complexes Based on (Quaternized) Poly [(2‐dimethylamino) ethyl methacrylate]: Behavior in Contact with Blood | |
| JPS60250015A (en) | Permselective resin | |
| Lowe et al. | Thermal and rheological properties of hydrophobically modified responsive gels | |
| JPH07500126A (en) | polyacrylamide gel matrix | |
| Zhuang et al. | Preparation and separation function of N‐isopropylacrylamide copolymer hydrogels | |
| JP2587808B2 (en) | Water separation retention release agent | |
| JPS60250019A (en) | Resin for water-based gel | |
| JPS61263641A (en) | Water-swelling agent | |
| JPH0550332B2 (en) | ||
| JPS60250017A (en) | Resin for concentration control | |
| JPS60250016A (en) | Resin for retaining and releasing useful substance | |
| JPS61263638A (en) | Method for preventing caking of water-separating and retaining agent | |
| JPS6323808B2 (en) | ||
| Zhang et al. | Preparation and super-water-absorbency of poly (sodium acrylate-co-acrylamide-co-2-hydroxyethyl acrylate) | |
| JPS62135504A (en) | High-molecular porous material | |
| JPS60250013A (en) | Resin for moisture conditioning |